Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
BBAI Ultimate Holdings, LLC BBAI BigBear.ai Holdings, Inc. 13D/A 64.8% 2y
Cormorant Asset Management, LP CRBP Corbus Pharmaceuticals Holdings, Inc. 13G/A 19.3% 2y
GLAZER CAPITAL, LLC HARP Harpoon Therapeutics, Inc. Common Stock 13G 0% 2y
SCOGGIN MANAGEMENT LP WKSP Worksport Ltd 13G 2.46% 2y
John C. Klock, Jr. QTI Qt Imaging Holdings, Inc. 13D 13.4% 2y
GigAcquisitions5, LLC QTI Qt Imaging Holdings, Inc. 13D 33.7% 2y
Aquilo Capital Management, LLC DTIL Precision Biosciences Inc 13G 9.9% 2y
A.L. Sarroff Fund, LLC PETV PetVivo Holdings, Inc. 13G/A 11.75% 2y
M&G INVESTMENT MANAGEMENT LTD CRGO Freightos Ltd 13D 19.5% 2y
Tal Barnoach BMR Beamr Imaging Ltd. 13G 7.4% 2y
Scott Tarriff EGRX Eagle Pharmaceuticals, Inc. 13G/A 17.6% 2y
Timothy J. Langer TSBX Turnstone Biologics Corp. Common Stock 13G 5.6% 2y
GIP II Blue Holding, L.P. HESM Hess Midstream LP 13D/A 43.3% 2y
Deerfield Management Company, L.P. LRMR Larimar Therapeutics, Inc. 13D/A 33.32% 2y
INCLUSIVE CAPITAL PARTNERS, L.P. STRA Strategic Education, Inc. 13D/A 6.7% 2y
Hess Investments North Dakota LLC HESM Hess Midstream LP 13D/A 51.8% 2y
Stellantis N.V. ACHR Archer Aviation Inc. 13D/A 16.5% 2y
Michael B. Chancellor LIPO Lipella Pharmaceuticals Inc. 13D/A 20% 2y
CB SNOWBIRD HOLDINGS, L.P. HCI HCI Group, Inc. 13D/A 4.76% 2y
Gerald E. O’Shaughnessy GPRK GeoPark Ltd 13D/A 5.05% 2y
Jonathan H. Kaufman LIPO Lipella Pharmaceuticals Inc. 13D/A 19.5% 2y
UDQ Private Trust Company, LLC, solely as trustee of the trusts listed on Appendix A -1 and Appendix A-2. H Hyatt Hotels Corp 13D/A 17.3% 2y
Dragasac Ltd CELU Celularity Inc 13D/A 34.2% 2y
Fund 1 Investments, LLC BJRI BJs RESTAURANTS INC 13D/A 9.96% 2y
Mark Comora OPAL OPAL Fuels Inc. 13D/A 84.2% 2y
Saba Capital Management, L.P. HQH abrdn Healthcare Investors 13D 5.17% 2y
Joseph Reda UAVS AgEagle Aerial Systems Inc. 13G 6.16% 2y
White Lion Capital, LLC AUUD Auddia Inc. 13G 9.77% 2y
David B. Blundin EVER EverQuote, Inc. 13D/A 25.9% 2y
Jean-Pierre De Villiers LEAT Leatt Corp 13D/A 0.4% 2y
Deep Track Capital, LP DFTX Definium Therapeutics, Inc. 13G 9.49% 2y
GENERAL ATLANTIC, L.P. AKRO Akero Therapeutics, Inc. Common Stock 13G 7.7% 2y
TCG Crossover GP II, LLC NKTR Nektar Therapeutics 13G 9.9% 2y
Tontine Capital Partners, L.P. IESC IES Holdings, Inc. 13D/A 56.4% 2y
Cowen Overseas Investment LP 000000000 STHO Star Holdings 13G/A 7.34% 2y
MFN Partners, LP SBNY Signature Bank 13G 9.5% 2y
American Industrial Partners Capital Fund IV, LP REVG REV Group, Inc. 13G/A 3.4% 2y
Michael Bigger BFRI Biofrontera Inc. 13G 9.99% 2y
Cowen Overseas Investment LP 000000000 STHO Star Holdings 13G/A 8.13% 2y
Cowen Overseas Investment LP 000000000 STHO Star Holdings 13G 5.08% 2y
Lance S. Gad, Trustee, Lance S. Gad Revocable Trust U/A DTD 05/14/2018 GYRO Gyrodyne, LLC 13G 7.6% 2y
TOWERVIEW LLC GYRO Gyrodyne, LLC 13G/A 15.6% 2y
South Dakota Investment Council VTOL Bristow Group Inc. 13D/A 16.4% 2y
Altria Group, Inc. BUD Anheuser-Busch InBev SA 13D/A 57% 2y
Saba Capital Management, L.P. NAC Nuveen California Quality Municipal Income Fund 13D/A 6.09% 2y
Columbia Capital IV, LLC NN Nextnav Inc. 13D/A 7% 2y
Meridian Venture Partners II GP, L.P. ("GP") ANIP Ani Pharmaceuticals Inc 13D/A 6.9% 2y
Oaktree Capital Holdings, LLC TRMD TORM plc 13D/A 56.14% 2y
Onex Corporation RYAN Ryan Specialty Holdings, Inc. 13D/A 3.5% 2y
LCP Edge Holdco, LLC SKIN SkinHealth Systems Inc. 13D/A 27.03% 2y